Evidence map›Paper›PMID 21059422›Full record

Trial reportBone2011

Longitudinal evaluation of the effects of alendronate on MRI bone microarchitecture in postmenopausal osteopenic women.

Jenny Folkesson, Janet Goldenstein, Julio Carballido-Gamio, Galateia Kazakia, Andrew J Burghardt, Ana Rodriguez, Roland Krug, Anne E de Papp, Thomas M Link, Sharmila Majumdar

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Bone, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. The clinical application of high-resolution peripheral computed tomography (HR-pQCT) in adults: state of the art and future directions.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021
    Review
  4. Survey of MRI Usefulness for the Clinical Assessment of Bone Microstructure.International journal of molecular sciences · 2021
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. MRI assessment of bone structure and microarchitecture.Journal of magnetic resonance imaging : JMRI · 2017
    Review
  10. Advances in imaging approaches to fracture risk evaluation.Translational research : the journal of laboratory and clinical medicine · 2017
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. A trimodality comparison of volumetric bone imaging technologies. Part I: Short-term precision and validity.Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry
    Observational
  20. A Trimodality Comparison of Volumetric Bone Imaging Technologies. Part II: 1-Yr Change, Long-Term Precision, and Least Significant Change.Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jenny FolkessonMusculoskeletal Quantitative Imaging Research Group (MQIR), Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA. jenny.folkesson@ucsf.edu
Janet Goldenstein
Julio Carballido-Gamio
Galateia Kazakia
Andrew J Burghardt
Ana Rodriguez
Roland Krug
Anne E de Papp
Thomas M Link
Sharmila Majumdar
University of California, San Francisco · USMerck & Co., Inc., Rahway, NJ, USA (United States) · US

Funding

Morphological and Functional Musko-Skeletal ImagingR01AG017762 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MAJUMDAR, SHARMILA · 2000 to 2011
$9.1M
In vivo imaging of cortical porosity in the peripheral skeletonK01AR056734 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KAZAKIA, GALATEIA J · 2009 to 2013
$594k
NIAMS NIH HHS K01 AR056734NIA NIH HHS R01 AG017762NIA NIH HHS R01 AG1776
6 · The paper itself

Abstract

unlabelledWe evaluated longitudinal effects of alendronate on MRI-based trabecular bone structure parameters derived from dual thresholding and fuzzy clustering (BE-FCM) trabecular bone segmentation. Treatment effects were observed in the distal tibia after 24 months. The BE-FCM method increased correlations to HR-pQCT-based parameters.

introductionHigh-resolution magnetic resonance imaging (MRI) allows for non-invasive bone microarchitecture analysis. The goal of this study was to examine the potential of MRI-based trabecular bone structure parameters to monitor effects of alendronate in humans in vivo, and to compare the results to HR-pQCT and DXA measurements. MATERIALS AND

methodsPostmenopausal osteopenic women were divided into alendronate treatment and control groups, and imaged at baseline, 12 months, and 24 months (n = 52 at baseline) using 3T MRI, HR-pQCT, and DXA. Image acquisition sites included distal tibia (MRI and HR-pQCT), distal radius (MRI, DXA, and HR-pQCT), and the proximal femur (MRI and DXA). Two different regions of interest were evaluated. One contained the trabecular bone region within the entire MRI acquisition, and the second contained a subregion matched to the region contained in the HR-pQCT acquisition. The trabecular bone was segmented using two different methods; dual thresholding and BE-FCM. Trabecular bone structure parameters included bone volume fraction (BV/TV), number (Tb.N), spacing (Tb.Sp), and thickness (Tb.Th), along with seven geodesic topological analysis (GTA) parameters. Longitudinal changes and correlations to HR-pQCT and DXA measurements were evaluated.

resultsApparent Tb.N and four GTA parameters showed treatment effects (p < 0.05) in the distal tibia after 24 months in the entire MRI region using BE-FCM, as well as Tb.N using dual thresholding. No treatment effects after 24 months were observed in the HR-pQCT or in MRI analysis for the HR-pQCT-matched regions. Apparent BV/TV and Tb.N from BE-FCM had significantly higher correlations to HR-pQCT values compared to those derived from thresholding.

conclusionsThis study demonstrates the influence of computational methods and region of interest definitions on measurements of trabecular bone structure, and the feasibility of MRI-based quantification of longitudinal changes in bone microarchitecture due to bisphosphonate therapy. The results suggest that there may be a need to reevaluate the current standard HR-pQCT region definition for increased treatment sensitivity.

Indexed as

Magnetic Resonance ImagingAbsorptiometry, PhotonAgedAlendronateBone and BonesBone DensityBone Density Conservation AgentsBone Diseases, MetabolicFemaleFuzzy LogicHumansLongitudinal StudiesMiddle AgedPostmenopauseTomography, X-Ray ComputedAlendronateBone Density Conservation Agents

Identifiers

PMID21059422
PMCPMC4461063
OpenAlexW1964698982

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.